Investigation Report on China's Gliclazide Market, 2018-2022

Publisher Name :
Date: 14-Sep-2018
No. of pages: 30

Description

The overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end of 2017, and is still rising.

Taken by mouth, Gliclazide is a second-generation sulfonylurea to treat diabetes by stimulating insulin secretion from pancreatic ?-cells. It can protect pancreatic ?-cells from the apoptosis caused by hyperglycemia, and prevent atherosclerosis (build-up of fatty deposits in the arteries) caused by type 2 diabetes.

Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and entered China in the 1980s. In China, at least 200,000 people with type 2 diabetes are taking Gliclazide every year.

In 1987, Tianjin Huajin Pharmaceutical Factory (now known as Tianjin Huajin Pharmaceutical Co., Ltd.) started cooperating with Servier and Tianjin Pharmaceutical Station to produce Gliclazide (Diamicron), a new drug to treat type 2 diabetes. With the support of Servier, the company has been taking the leading position on China's Gliclazide market. Also dominating the market are Servier and Servier (Tianjin) Pharmaceutical Co., Ltd., the joint venture of Servier and Tianjin Huajin Pharmaceutical Co., Ltd.

According to CRI, the sales value of Gliclazide kept rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China's Gliclazide market will continue to grow as the incidence of type 2 diabetes rises.

Investigation Report on China's Gliclazide Market, 2018-2022

Table of Contents
1 Relevant Concepts of Gliclazide
1.1 Indications for Gliclazide
1.2 Development History of Gliclazide in China
1.3 Governmental Approval of Gliclazide in China

2 Sales of Gliclazide in China, 2013-2017
2.1 Sales Value
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Gliclazide by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 Analysis on Major Gliclazide Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Gliclazide Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Servier
3.2.1 Enterprise Profile
3.2.2 Sales of Servier's Gliclazide in China
3.3 Servier (Tianjin) Pharmaceutical Co., Ltd.
3.4 Tianjin Huajin Pharmaceutical Co. Ltd.
3.5 Nanchang Helioeast Pharmaceutical Co., Ltd.
3.6 Guilin Hwasun Pharmaceutical Co., Ltd.

4 Prices of Gliclazide in China, 2017-2018
4.1 Servier (Diamicron)
4.2 Servier (Tianjin) Pharmaceutical Co., Ltd. (Diamicron)
4.3 Tianjin Huajin Pharmaceutical Co. Ltd. (Diamicron)
4.4 Nanchang Helioeast Pharmaceutical Co., Ltd. (Hongxuyang)
4.5 Guilin Hwasun Pharmaceutical Co., Ltd. (Xieerping)

5 Prospect of China's Gliclazide Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

Selected Charts
Chart Sales of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide in Parts of China, 2013-2017
Chart Sales Volume of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide Tablets in China, 2013-2017
Chart Sales Value of Gliclazide Capsules in China, 2013-2017
Chart Market Share of Top 5 Gliclazide Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Servier
Chart Sales Value of Servier's Gliclazide in China, 2013-2017
Chart Sales Value of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in China, 2013-2017
Chart Sales Value of Servier Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in China, 2013-2017
Chart Prices of Servier's Gliclazide in Parts of China, 2017-2018
Chart Prices of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Prices of Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Governmental Approval of Gliclazide in China
Chart Forecast on Sales Value of Gliclazide in China, 2018-2012
  • Global Insulin (API & Injection) Market Insights, Forecast to 2025
    Published: 08-Nov-2018        Price: US 3900 Onwards        Pages: 110
    This report studies the global market size of Insulin (API & Injection) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin (API & Injection) in these regions. This research report categorizes the global Insulin (API & Injection) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends......
  • Global Lixisenatide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 07-Nov-2018        Price: US 3480 Onwards        Pages: 108
    Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of diabetes type II. Scope of the Report: The growth of the global lixisenatide market is driven by increase in prevalence diabetes and surge in overweight populace. Moreover, unhealthy urban lifestyle and increase number of fast food eating populace susceptible to sudden weight gain are expected to boost the market growth. However, number of limited man......
  • Global Human Insulin Market Data Survey Report 2025
    Published: 04-Nov-2018        Price: US 1500 Onwards        Pages: 73
    Summary The global Human Insulin market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity and pr......
  • Investigation Report on China's Acarbose Market, 2018-2022
    Published: 01-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Description According to CRI, with improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in China. By the end of 2017, the number of diabetic patients in China exceeded 100 million, ranking first in the world and promoting the development of the diabetes drug market. Acarbose was developed by Bayer in 1975 and first launched in Switzerland in 1986 (trade name: Glucobay). As the first FDA-approved......
  • Investigation Report on China's Insulin Aspart Market, 2018-2022
    Published: 01-Nov-2018        Price: US 2200 Onwards        Pages: 30
    Description The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities, which leads to an increasing incidence of obesity-related diseases. It is estimated that at the end of 2017, there were more than 100 million diabetic patients in China. The market size of diabetes drugs is also growing in China. On Dec. 26, 2001, Novo Nordisk announced that Insulin Aspart (trade name: NovoRapi......
  • Global Metformin Hydrochloride Market Research Report 2018
    Published: 01-Nov-2018        Price: US 2900 Onwards        Pages: 110
    This report studies the global Metformin Hydrochloride market status and forecast, categorizes the global Metformin Hydrochloride market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Bristol-Mayers Squibb - Shouguang Fukang Pharmaceutical - Harman Finochem......
  • Global Lixisenatide Market Insights, Forecast to 2025
    Published: 30-Oct-2018        Price: US 3900 Onwards        Pages: 115
    This report studies the global market size of Lixisenatide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lixisenatide in these regions. This research report categorizes the global Lixisenatide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and cha......
  • Global Insulin Glargine Market Research Report 2018
    Published: 30-Oct-2018        Price: US 2900 Onwards        Pages: 112
    This report studies the global Insulin Glargine market status and forecast, categorizes the global Insulin Glargine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Sanofi-Aventis - Ganlee - Biocon Geographically, this report studies the top p......
  • Global Insulin Lispro Market Research Report 2018
    Published: 26-Oct-2018        Price: US 2900 Onwards        Pages: 111
    This report studies the global Insulin Lispro market status and forecast, categorizes the global Insulin Lispro market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Eli Lilly and Company - Gan & Lee Pharmaceuticals Geographically, this report studies the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs